Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL

TNF-related apoptosis-inducing ligand (TRAIL, also known as Apo-2L) is a promising novel anticancer agent that selectively induces apoptosis in tumour cells and the activity of which can be enhanced by combined treatment with chemo- or radiotherapy. For therapeutic purposes, the use of full-length T...

Descripción completa

Detalles Bibliográficos
Autores principales: Abou El Hassan, M A I, Mastenbroek, D C J, Gerritsen, W R, Giaccone, G, Kruyt, F A E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364740/
https://www.ncbi.nlm.nih.gov/pubmed/15173860
http://dx.doi.org/10.1038/sj.bjc.6601910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364740/
https://www.ncbi.nlm.nih.gov/pubmed/15173860
http://dx.doi.org/10.1038/sj.bjc.6601910

Ejemplares similares